[Treat-to-target from the perspective of office-based rheumatology]

Z Rheumatol. 2011 Oct;70(8):664-9. doi: 10.1007/s00393-011-0852-0.
[Article in German]


The development of evidence-based treat-to-target (T2T) recommendations alleviates decision-making for the rheumatologist and simultaneously promises substantial improvement of outcome for rheumatoid arthritis (RA) patients. For the office-based rheumatologist in Germany, however, implementation of T2T recommendations contains several difficulties. Limitations arise as a result of an insufficient number of rheumatologists as well as a lack of adequate remuneration both resulting in a lack of time for the individual RA patient. Furthermore budget limitations hinder the appropriate use of antirheumatic drugs and insofar counteract treating to the target of remission. Establishment of selective contracts for rheumatologists by health insurance funds might reduce many of these problems in future for the office-based rheumatologist in Germany.

Publication types

  • Review

MeSH terms

  • Antirheumatic Agents / economics
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / economics
  • Evidence-Based Medicine* / economics
  • Fee Schedules
  • Forecasting
  • Germany
  • Health Services Needs and Demand / economics
  • Humans
  • National Health Programs* / economics
  • Private Practice* / economics
  • Quality Improvement / economics
  • Reimbursement Mechanisms / economics
  • Rheumatology* / economics
  • Workforce


  • Antirheumatic Agents